We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

131 hedge funds and large institutions have $645M invested in Arena Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 31

3% more capital invested

Capital invested by funds: $629M → $645M (+$15.9M)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 134 → 131 (-3)

46% less call options, than puts

Call options by funds: $29.8M | Put options by funds: $54.7M

Holders
131
Holders Change
-3
Holders Change %
-2.24%
% of All Funds
3.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
48
Reduced
31
Closed
22
Calls
$29.8M
Puts
$54.7M
Net Calls
-$24.9M
Net Calls Change
+$1.98M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$6.63M
2
Goldman Sachs
Goldman Sachs
New York
+$5.93M
3
Invesco
Invesco
Georgia
+$4.16M
4
CA
Commerzbank Aktiengesellschaft
Germany
+$2.42M
5
Morgan Stanley
Morgan Stanley
New York
+$2.33M

Top Sellers

Rank Fund Capital Flow
1
SC
Samlyn Capital
New York
-$21.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$4.12M
4
VanEck Associates
VanEck Associates
New York
-$3.44M
5
CS
Credit Suisse
Switzerland
-$3.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$174M -$16.4M -247,488 -8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$84.1M -$4.12M -62,060 -4%
BFA
3
BlackRock Fund Advisors
California
$52.8M +$2.11M +31,755 +4%
State Street
4
State Street
Massachusetts
$45.4M +$272K +4,098 +0.6%
O
5
OppenheimerFunds
New York
$44.1M +$6.63M +100,000 +17%
BIT
6
BlackRock Institutional Trust
California
$39M +$955K +14,400 +2%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$23M -$1.38M -20,806 -5%
Northern Trust
8
Northern Trust
Illinois
$18.2M -$1.79M -26,916 -9%
Invesco
9
Invesco
Georgia
$11.6M +$4.16M +62,686 +51%
Norges Bank
10
Norges Bank
Norway
$10.6M – – –
Goldman Sachs
11
Goldman Sachs
New York
$8.79M +$5.93M +89,446 +179%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$7.89M +$36.2K +546 +0.4%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$7.69M +$947K +14,273 +13%
DM
14
Deerfield Management
New York
$7.66M – – –
BA
15
BlackRock Advisors
Delaware
$7M +$462K +6,965 +7%
Morgan Stanley
16
Morgan Stanley
New York
$6.54M +$2.33M +35,093 +51%
TCIM
17
TIAA CREF Investment Management
New York
$6.32M -$33.6K -506 -0.5%
TA
18
Teachers Advisors
New York
$5.71M +$39.2K +591 +0.7%
GC
19
Guggenheim Capital
Illinois
$5.01M +$1.35M +20,422 +35%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$4.44M +$341K +5,141 +8%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$4.15M – – –
Deutsche Bank
22
Deutsche Bank
Germany
$4.13M -$2.58M -38,923 -37%
BIM
23
BlackRock Investment Management
Delaware
$3.9M +$22K +332 +0.5%
Charles Schwab
24
Charles Schwab
California
$3.66M +$308K +4,638 +9%
Bank of America
25
Bank of America
North Carolina
$3.52M +$184K +2,779 +5%
1
2 3 4 5

ARNA Hedge Fund Activity: Q1 2014 in Review

131 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2014, worth a combined $645M — up 2.5% from $629M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ARNA and 21 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 48 added.

The largest buyer was OppenheimerFunds, adding an estimated $6.63M. The largest seller was Samlyn Capital, exiting entirely with an estimated $21.4M sold.

  • 131 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2014, down from 134 in Q4 2013.
  • Funds reported $645M of Arena Pharmaceuticals Inc stock for Q1 2014, up 2.5% quarter-over-quarter.
  • 21 funds opened new Arena Pharmaceuticals Inc positions in Q1 2014 and 22 closed out, a net change of -1 holder.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2014 was OppenheimerFunds, an estimated $6.63M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2014 was Samlyn Capital, an estimated $21.4M sold.

Based on aggregated 13F filings for Q1 2014.